Sign in
4

Changes in Ownership

PUMA BIOTECHNOLOGY, INC. Filed Acc 0001437749-24-000770

President and CEO sold 41,396 shares at $4.49 ($185,698)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
AUERBACH ALAN H President and CEO 2024-01-03 Sale 10b5-1 −41,396 $4.49 $185,698 6,936,947 D
Open-market sales · 41,396 sh · avg $4.49 · $185,698
Loading xslF345X05/rdgdoc.xml…